Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tazarotene gel may be more effective for acne than adapalene gel.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

The committee decided not to approve the drug due to low effectiveness and high risks.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

CTP-543 is generally safe for treating alopecia areata.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The treatment is safe and shows promise for metastatic breast cancer.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Tenofovir alafenamide fumarate is effective and safer for hepatitis B, with fewer side effects than tenofovir disoproxil fumarate.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.